Aardvark Therapeutics, Inc. Common Stock (AARD) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.05HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.78HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AARD vs LENZ
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)LENZ -85.5% (-62.0%/yr)AARD compounded faster over this window
AARD LENZ
AARD vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $110M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | AARD | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.52 |
| P/B ratio | 1.48 | 0.54 |
Profitability
| Metric | AARD | LENZ |
|---|---|---|
| Gross margin | 0.00% | 90.14% |
| Operating margin | 0.00% | -477.46% |
| Net margin | 0.00% | -586.74% |
| ROE | -93.44% | -57.47% |
| ROIC | -97.99% | -61.84% |
Growth (annualized)
| Metric | AARD | LENZ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -35.49% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROELENZ Therapeutics ROEAardvark Therapeutics, Inc. Common Stock operating marginLENZ Therapeutics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthLENZ Therapeutics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowLENZ Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.